Learn About Microcephalic Osteodysplastic Primordial Dwarfism Type 1

What is the definition of Microcephalic Osteodysplastic Primordial Dwarfism Type 1?
Microcephalic osteodysplastic primordial dwarfism type 1 (MOPD1) is a genetic condition that is mainly characterized by intrauterine and post-natal growth retardation; an abnormally small head size (microcephaly); abnormal bone growth (skeletal dysplasia); distinctive facial features; and brain anomalies. Other signs and symptoms include sparse hair and eyebrows; dry skin; short limbs; dislocation of the hips and elbows; seizures; and intellectual disability. It is caused by mutations in the RNU4ATAC gene and is inherited in an autosomal recessive manner. Treatment is supportive only. The prognosis is poor with most affected individuals dying within the first year of life. MOPD types 1 and 3 were originally thought to be separate entities, but more recent reports have confirmed that the two forms are part of the same syndrome.
Save information for later
Sign Up
What are the alternative names for Microcephalic Osteodysplastic Primordial Dwarfism Type 1?
  • MOPD 1
  • Microcephalic osteodysplastic primordial dwarfism types 1 and 3
  • Osteodysplastic primordial dwarfism type I
  • Brachymelic primordial dwarfism
  • Taybi-Linder syndrome
  • Primordial microcephalic dwarfism, Crachami type
  • Cephaloskeletal dysplasia
  • Low-birth-weight dwarfism with skeletal dysplasia
What are the causes of Microcephalic Osteodysplastic Primordial Dwarfism Type 1?
Microcephalic osteodysplastic primordial dwarfism type 1 (MOPD1) has been shown to be caused by mutations in the RNU4ATAC gene.
What are the symptoms of Microcephalic Osteodysplastic Primordial Dwarfism Type 1?
Individuals with MOPD1 may have low birth weight, growth retardation, short limbs, broad hands, small head size (microcephaly), abnormal bone growth (skeletal dysplasia) and a distinct facial appearance. Facial characteristics may include a sloping forehead; protruding eyes; prominent nose with a flat nasal bridge; and small jaw (micrognathia). In addition, babies with MOPD1 may experience short episodes of stopped breathing (apnea) and seizures. Affected individuals also commonly have sparse hair and eyebrows; dry skin; dislocation of the hips or elbows; and intellectual disability. Brain abnormalities that have been reported include lissencephaly, hypoplastic (underdeveloped) frontal lobes, and agenesis of the corpus callosum or cerebellar vermis (the nerve tissue that connects the two halves of the cerebellum).
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Microcephalic Osteodysplastic Primordial Dwarfism Type 1?
At this time there are no specific treatments for MOPD1. Treatment is generally supportive. The prognosis is poor for affected individuals, with most of the reported patients dying within the first year of life.
Who are the top Microcephalic Osteodysplastic Primordial Dwarfism Type 1 Local Doctors?
Distinguished
Highly rated in
23
conditions

University Medical Center Göttingen

Goettingen, NI, DE 

Gokhan Yigit is in Goettingen, Germany. Yigit is rated as a Distinguished expert by MediFind in the treatment of Microcephalic Osteodysplastic Primordial Dwarfism Type 1. They are also highly rated in 23 other conditions, according to our data. Their top areas of expertise are Microcephalic Osteodysplastic Primordial Dwarfism Type 1, Microcephalic Osteodysplastic Primordial Dwarfism Type 2, Microcephaly, and Achalasia Microcephaly Syndrome.

Distinguished
Highly rated in
41
conditions

King Faisal Specialist Hospital & Research Center

Riyadh, SA 

Ranad Shaheen is in Riyadh, Saudi Arabia. Shaheen is rated as a Distinguished expert by MediFind in the treatment of Microcephalic Osteodysplastic Primordial Dwarfism Type 1. They are also highly rated in 41 other conditions, according to our data. Their top areas of expertise are Meningoencephalocele, Meckel Syndrome, Encephalocele, and Seckel Syndrome.

 
 
 
 
Learn about our expert tiers
Learn more
Distinguished
Highly rated in
23
conditions

University Of Edinburgh

Glasgow, SCT, GB 

Andrew Jackson is in Glasgow, United Kingdom. Jackson is rated as a Distinguished expert by MediFind in the treatment of Microcephalic Osteodysplastic Primordial Dwarfism Type 1. He is also highly rated in 23 other conditions, according to our data. His top areas of expertise are Microcephalic Osteodysplastic Primordial Dwarfism Type 2, Seckel Syndrome, Microcephalic Osteodysplastic Primordial Dwarfism Type 1, and Meier-Gorlin Syndrome.

What is the outlook (prognosis) for Microcephalic Osteodysplastic Primordial Dwarfism Type 1?
Prognosis can vary from patient to patient, however it is generally poor. Some babies are stillborn. Most infants pass away with in a year, often due to infectious diseases.
Is Microcephalic Osteodysplastic Primordial Dwarfism Type 1 an inherited disorder?
MOPD1 is thought to be inherited in an autosomal recessive manner. This means that affected individuals have abnormal gene changes (mutations) in both copies of the disease-causing gene, with one copy inherited from each parent. The parents who each carry one abnormal copy of the gene are referred to as carriers; carriers typically do not show signs or symptoms of an autosomal recessive condition. When two carriers have children, each child has a 25% (1 in 4) risk to have the condition, a 50% (1 in 2) risk to be a carrier like each of the parents, and a 25% chance to not have the condition and not be a carrier.
What are the latest Microcephalic Osteodysplastic Primordial Dwarfism Type 1 Clinical Trials?
Primordial Registry at Nemours/Alfred I. duPont Hospital for Children
Match to trials
Find the right clinical trials for you in under a minute
Get started
Metabolic Study of Cockayne Syndrome
What are the Latest Advances for Microcephalic Osteodysplastic Primordial Dwarfism Type 1?

There is no recent research available for this condition. Please check back because thousands of new papers are published every week and we strive to find and display the most recent relevant research as soon as it is available.